» Articles » PMID: 37978062

Machine Learning Insights: Predicting Hepatic Encephalopathy After TIPS Placement

Overview
Date 2023 Nov 17
PMID 37978062
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To develop and assess machine learning (ML) models' ability to predict post-procedural hepatic encephalopathy (HE) following transjugular intrahepatic portosystemic shunt (TIPS) placement.

Materials And Methods: In this retrospective study, 327 patients who underwent TIPS for hepatic cirrhosis between 2005 and 2019 were analyzed. Thirty features (8 clinical, 10 laboratory, 12 procedural) were collected, and HE development regardless of severity was recorded one month follow-up. Univariate statistical analysis was performed with numeric and categoric data, as appropriate. Feature selection is used with a sequential feature selection model with fivefold cross-validation (CV). Three ML models were developed using support vector machine (SVM), logistic regression (LR) and CatBoost, algorithms. Performances were evaluated with nested fivefold-CV technique.

Results: Post-procedural HE was observed in 105 (32%) patients. Patients with variceal bleeding (p = 0.008) and high post-porto-systemic pressure gradient (p = 0.004) had a significantly increased likelihood of developing HE. Also, patients having only one indication of bleeding or ascites were significantly unlikely to develop HE as well as Budd-Chiari disease (p = 0.03). The feature selection algorithm selected 7 features. Accuracy ratios for the SVM, LR and CatBoost, models were 74%, 75%, and 73%, with area under the curve (AUC) values of 0.82, 0.83, and 0.83, respectively.

Conclusion: ML models can aid identifying patients at risk of developing HE after TIPS placement, providing an additional tool for patient selection and management.

Citing Articles

Can Artificial Intelligence and Machine Learning Transform Prediction and Treatment of Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Overt Hepatic Encephalopathy?.

Kalo E, Read S, George J, Majumdar A, Ahlenstiel G Gastro Hep Adv. 2025; 4(2):100560.

PMID: 39877867 PMC: 11772942. DOI: 10.1016/j.gastha.2024.09.015.


Optimal threshold of portal pressure gradient for patients with ascites after covered TIPS: a multicentre cohort study.

Xia Y, Tie J, Wang G, Wu H, Zhuge Y, Yuan X Hepatol Int. 2024; 19(1):199-211.

PMID: 39521751 PMC: 11846747. DOI: 10.1007/s12072-024-10742-x.


Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment.

Xu X, Yang Y, Tan X, Zhang Z, Wang B, Yang X Comput Struct Biotechnol J. 2024; 24:493-506.

PMID: 39076168 PMC: 11284497. DOI: 10.1016/j.csbj.2024.07.008.

References
1.
Sun S, Eche T, Dorczynski C, Otal P, Revel-Mouroz P, Zadro C . Predicting death or recurrence of portal hypertension symptoms after TIPS procedures. Eur Radiol. 2022; 32(5):3346-3357. DOI: 10.1007/s00330-021-08437-0. View

2.
Garcia-Pagan J, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A . Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010; 362(25):2370-9. DOI: 10.1056/NEJMoa0910102. View

3.
Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A . Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. Gastroenterology. 2016; 152(1):157-163. DOI: 10.1053/j.gastro.2016.09.016. View

4.
Shawcross D, Shabbir S, Taylor N, Hughes R . Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2009; 51(3):1062-9. DOI: 10.1002/hep.23367. View

5.
Li X, Partovi S, Coronado W, Gadani S, Martin C, Thompson D . Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management. Cardiovasc Intervent Radiol. 2022; 45(5):570-577. DOI: 10.1007/s00270-021-03045-3. View